- 
             Something wrong with this record ?
 
Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic
P. Jansa, R. Becvar, D. Ambroz, T. Palecek, M. Tomcik, S. Skacelova, M. Aschermann, A. Linhart,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
 NLK 
   
      ProQuest Central
   
    from 1997-01-01 to 2017-12-31
   
      Medline Complete (EBSCOhost)
   
    from 2000-01-01 to 1 year ago
   
      Health & Medicine (ProQuest)
   
    from 1997-01-01 to 2017-12-31
    
- MeSH
- Pulmonary Artery physiopathology MeSH
- Adult MeSH
- Cohort Studies MeSH
- Comorbidity MeSH
- Middle Aged MeSH
- Humans MeSH
- Lung physiopathology MeSH
- Hypertension, Pulmonary complications diagnosis epidemiology physiopathology MeSH
- Prevalence MeSH
- Respiratory Function Tests MeSH
- Aged MeSH
- Scleroderma, Systemic complications epidemiology physiopathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Systemic sclerosis (SSc) is an important cause of pulmonary arterial hypertension (PAH), with an estimated prevalence of 7.85-26.7%. OBJECTIVE: Our aim was to estimate the prevalence of PAH among patients with SSc in the Czech Republic and to compare haemodynamics in SSc patients diagnosed with PAH through screening with those diagnosed previously, based on symptoms. METHODS: During 2007, SSc patients in the Czech Republic, without significant pulmonary function impairment or cardiac disease, underwent screening for PAH with transthoracic echocardiography. Those with a tricuspid regurgitant (TR) jet gradient suggestive of PAH (>30 mmHg) underwent subsequent right heart catheterisation (RHC) to confirm the diagnosis (mean pulmonary arterial pressure, mPAP, ≥25 mmHg; pulmonary capillary wedge pressure, ≤15 mmHg). Haemodynamics in patients diagnosed with PAH in this way were compared with those in patients diagnosed previously, based on symptoms. RESULTS: Two hundred and three SSc patients (mean age, 53.8 ± 13 years; 82.3% women) from 26 rheumatology practices were screened. Among these, 17 had a TR jet gradient >30 mmHg and underwent RHC; PAH was confirmed in six patients. These six patients were found to have significantly lower mPAP than nine patients diagnosed previously with PAH, based on symptoms (31.17 ± 5.56 vs. 46.89 ± 9.48 mmHg, p = 0.0014). CONCLUSION: Prevalence of PAH in our SSc cohort was 7.08%. SSc patients diagnosed with PAH through screening have less advanced disease in terms of haemodynamics than those with PAH diagnosed previously based on symptoms; their prognosis is therefore likely to be more favourable.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034853
- 003
- CZ-PrNML
- 005
- 20121206125331.0
- 007
- ta
- 008
- 121023s2012 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10067-011-1896-x $2 doi
- 035 __
- $a (PubMed)22105781
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Jansa, Pavel $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, Charles University, U nemocnice 2, Prague 2 12808, Czech Republic. jansapavel@yahoo.com
- 245 10
- $a Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic / $c P. Jansa, R. Becvar, D. Ambroz, T. Palecek, M. Tomcik, S. Skacelova, M. Aschermann, A. Linhart,
- 520 9_
- $a BACKGROUND: Systemic sclerosis (SSc) is an important cause of pulmonary arterial hypertension (PAH), with an estimated prevalence of 7.85-26.7%. OBJECTIVE: Our aim was to estimate the prevalence of PAH among patients with SSc in the Czech Republic and to compare haemodynamics in SSc patients diagnosed with PAH through screening with those diagnosed previously, based on symptoms. METHODS: During 2007, SSc patients in the Czech Republic, without significant pulmonary function impairment or cardiac disease, underwent screening for PAH with transthoracic echocardiography. Those with a tricuspid regurgitant (TR) jet gradient suggestive of PAH (>30 mmHg) underwent subsequent right heart catheterisation (RHC) to confirm the diagnosis (mean pulmonary arterial pressure, mPAP, ≥25 mmHg; pulmonary capillary wedge pressure, ≤15 mmHg). Haemodynamics in patients diagnosed with PAH in this way were compared with those in patients diagnosed previously, based on symptoms. RESULTS: Two hundred and three SSc patients (mean age, 53.8 ± 13 years; 82.3% women) from 26 rheumatology practices were screened. Among these, 17 had a TR jet gradient >30 mmHg and underwent RHC; PAH was confirmed in six patients. These six patients were found to have significantly lower mPAP than nine patients diagnosed previously with PAH, based on symptoms (31.17 ± 5.56 vs. 46.89 ± 9.48 mmHg, p = 0.0014). CONCLUSION: Prevalence of PAH in our SSc cohort was 7.08%. SSc patients diagnosed with PAH through screening have less advanced disease in terms of haemodynamics than those with PAH diagnosed previously based on symptoms; their prognosis is therefore likely to be more favourable.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a komorbidita $7 D015897
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plicní hypertenze $x komplikace $x diagnóza $x epidemiologie $x patofyziologie $7 D006976
- 650 _2
- $a plíce $x patofyziologie $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a arteria pulmonalis $x patofyziologie $7 D011651
- 650 _2
- $a respirační funkční testy $7 D012129
- 650 _2
- $a systémová sklerodermie $x komplikace $x epidemiologie $x patofyziologie $7 D012595
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Becvar, Radim
- 700 1_
- $a Ambroz, David $7 gn_A_00005391
- 700 1_
- $a Palecek, Tomas
- 700 1_
- $a Tomcik, Michal
- 700 1_
- $a Skacelova, Simona
- 700 1_
- $a Aschermann, Michael $7 nlk19990072993
- 700 1_
- $a Linhart, Ales
- 773 0_
- $w MED00001162 $t Clinical rheumatology $x 1434-9949 $g Roč. 31, č. 3 (2012), s. 557-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22105781 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20121206125404 $b ABA008
- 999 __
- $a ok $b bmc $g 956863 $s 792350
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 31 $c 3 $d 557-61 $i 1434-9949 $m Clinical rheumatology $n Clin Rheumatol $x MED00001162
- LZP __
- $a Pubmed-20121023
